3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1
1
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
173
Leukemia, Myeloid, Acute
153
Neoplasm Metastasis
145
Neoplasms
142
Breast Neoplasms
142
Colorectal Neoplasms
135
Recurrence
105
Ovarian Neoplasms
100
Pancreatic Neoplasms
81
Multiple Myeloma
81
Lung Neoplasms
81
Advanced Solid Tumor
80
Advanced Solid Tumors
74
Prostatic Neoplasms
73
Stomach Neoplasms
72
Squamous Cell Carcinoma of Head and Neck
72
Carcinoma, Hepatocellular
67
Glioblastoma
65
Melanoma
64
Lymphoma, Non-Hodgkin
63
Triple Negative Breast Neoplasms
57
Myelodysplastic Syndromes
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53
Lymphoma, B-Cell
53
Endometrial Neoplasms
52
Glioma
51
Lymphoma
49
Brain Neoplasms
46
Hematologic Neoplasms
44
Carcinoma, Renal Cell
44
Interventions
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Recruiting
×
Urogenital Diseases
×
Clear all
NCT07103018
2026-03-23
STRIKE-001
K36 Therapeutics, Inc.
Phase 1
Recruiting
144 enrolled